With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

The pharmaceutical company had slogged for 35 ... and you’ll see the red cursive Lilly logo on the jerseys of WNBA team the ...

Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in ... at approximately half the ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to ...

The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Since 2021, EVA Pharma has been working with Lilly to ensure a sustainable supply of life-saving medicines across several ...

As the company continues to push for GLP-1 market share, it has tapped an internal veteran with recent experience managing research and development finance.

The financial leadership transition is coming as the pharma giant hovers just below a $1 trillion market cap in the midst of rising demand for several new medications.